What is the catalog number for ERV3 Antibody (C-Term) [APR31117G]?

The catalog number for ERV3 Antibody (C-Term) [APR31117G] is APR31117G.

What sizes are available for ERV3 Antibody (C-Term) [APR31117G]?

ERV3 Antibody (C-Term) [APR31117G] is available in the following size(s): 50 µL, 100 µL, 200 µL, 400 µL.

How many pack sizes does ERV3 Antibody (C-Term) [APR31117G] come in?

ERV3 Antibody (C-Term) [APR31117G] is available in 4 different pack sizes.

Is ERV3 Antibody (C-Term) [APR31117G] in stock?

ERV3 Antibody (C-Term) [APR31117G] is currently made to order / not held in immediate stock. Contact us for lead time.

ERV3 Antibody (C-Term) [APR31117G]

Product Specifications

Background

Tissue Location: Expressed at higher level in adrenal, sebaceous glands and placenta. Expressed at lower level in bone marrow, brain, breast, colon, heart, kidney, liver, lung, ovary, PBL, prostate, skin, spleen, testis, thymus, thyroid, trachea

Overview

We constantly strive to ensure we provide our customers with the best antibodies. As a result of this work we offer this antibody in purified format. We are in the process of updating our datasheets. If you have any questions regarding this update, please feel free to contact our technical support team. This product is a high quality ERV3 Antibody (C-Term) [APR31117G].

Synonyms

Endogenous retrovirus group 3 member 1 Env polyprotein, ERV-3 envelope protein, ERV3 envelope protein, ERV3-1 envelope protein, Envelope polyprotein, HERV-R envelope protein, ERV-R envelope protein, HERV-R_7q212 provirus ancestral Env polyprotein, Surface protein, SU, Transmembrane protein, TM, ERV3-1, ERV3

Gene Name

ERV3-1

Gene ID

2086

UniProt

Q14264

Chromosomal Location

Virion.

Applications

WB, IHC-P

Dilution

WB--1:1000 IHC-P--1:100~500

Form

Purified polyclonal antibody supplied in PBS with 0.09% (W/V) sodium azide. This antibody is purified through a protein A column, followed by peptide affinity purification.

Function

Retroviral envelope proteins mediate receptor recognition and membrane fusion during early infection. Endogenous envelope proteins may have kept, lost or modified their original function during evolution. This endogenous envelope protein has lost its fusogenic properties. It can inhibit cell growth through decrease expression of cyclin B1 and increased expression of p21 in vitro.